Journal
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 16, Issue 5, Pages 551-576Publisher
SHENYANG PHARMACEUTICAL UNIV
DOI: 10.1016/j.ajps.2020.12.002
Keywords
Nano-drug delivery system; Hemocompatibility; Adverse interaction; Improvement strategy
Categories
Ask authors/readers for more resources
This article discusses the various blood interactions that may occur with various types of nano drug-loading systems, including inflammatory reactions and immune reactions, as well as the characteristics and coping strategies of adverse blood reactions.
This article discusses the various blood interactions that may occur with various types of nano drug-loading systems. Nanoparticles enter the blood circulation as foreign objects. On the one hand, they may cause a series of inflammatory reactions and immune reactions, resulting in the rapid elimination of immune cells and the reticuloendothelial system, affecting their durability in the blood circulation. On the other hand, the premise of the drug-carrying system to play a therapeutic role depends on whether they cause coagulation and platelet activation, the absence of hemolysis and the elimination of immune cells. For different forms of nano drug-carrying systems, we can find the characteristics, elements and coping strategies of adverse blood reactions that we can find in previous researches. These adverse reactions may include destruction of blood cells, abnormal coagulation system, abnormal effects of plasma proteins, abnormal blood cell behavior, adverse immune and inflammatory reactions, and excessive vascular stimulation. In order to provide help for future research and formulation work on the blood compatibility of nano drug carriers. (C) 2021 Shenyang Pharmaceutical University. Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available